BLLN BillionToOne, Inc.

90.20USD-1.46%Mkt Cap: 4.31B USDP/E: 98.04

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the sing…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap4.31B USD
Enterprise Value3.95B USD
Revenue (TTM)436.87M USD
Gross Profit208.46M USD
Net Income (TTM)7.45M USD
Revenue/Share10.16 USD
Last Price90.20 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees713
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)98.04
P/E (Forward)57.45
PEG—
EV/EBITDA76.14
EV/Revenue9.05
P/S9.86
P/B7.58
EPS (TTM)0.92 USD
EPS (Forward)1.57 USD
52W Range
61.9632% of range150.44
52W High150.44 USD
52W Low61.96 USD
Profitability
Gross Margin68.32%
Oper. Margin10.23%
EBITDA Margin11.88%
Profit Margin2.44%
ROE1.55%
ROA1.18%
ROIC16.55%
ROCE2.74%
Growth
Revenue Growth47.20%
Earnings Growth220.00%
Cash Flow & Leverage
Operating CF24.59M USD
CapEx (TTM)8.92M USD
FCF Margin2.72%
FCF Yield0.28%
Net Debt-421.06M USD
Net Debt/EBITDA-8.11
Net Debt/FCF-35.44
Balance Sheet
Debt/Equity0.23
Current Ratio11.25
Quick Ratio10.72
Book Value/Sh11.89 USD
Cash/Share11.75 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)128.29 USD
Upside (mean)+42.2%
Target Range110.00 USD – 145.00 USD
110.00+42.2% to mean145.00
# Analysts7
Ownership
Shares Out.43.27M
Float29.34M
Insiders28.28%
Institutions51.58%
Short Interest
Short Ratio5.8d
Short % Float11.15%
Short % Out.6.24%
Shares Short2.97M
Short (prev mo.)2.82M
Technical
SMA 50106.93 (-15.6%)
SMA 20097.72 (-7.7%)
Beta—
S&P 52W Chg12.08%
Avg Vol (30d)644.16K
Avg Vol (10d)827.75K
Technical Indicators
RSI (14)30.3
MACD-2.8940
MACD Signal-0.1853
MACD Hist.-2.7086
BB Upper124.02 USD
BB Middle108.26 USD
BB Lower92.50 USD
BB Width29.11%
ATR (14)6.806 USD
Vol Ratio (20d)1.28x

About BillionToOne (NASDAQ: BLLN)

›

BillionToOne (NASDAQ: BLLN) is listed on Nasdaq, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 713 employees.

The shares were at 90.20 USD on 19 November 2026, down 9.2% over 52 weeks. Its 52-week range is 61.96 USD to 150.44 USD: the price is 40.0% below the high and 45.6% above the low.

At a market capitalisation of 4.31B USD, it trades at 98.0 times trailing earnings and 57.5 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a premium of 174% for BLLN.

BillionToOne reports return on equity of 1.6%, an operating margin of 10.2% and revenue up 47.2% year over year.

It holds more cash than debt, a net cash position of 421.06M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 7 analysts cover the stock, with an average rating of Buy; their mean price target of 128.29 USD is 42.2% above the current price. The next earnings report is expected on 3 March 2027.